Mateon Therapeutics

Company Listings from SPi: Mateon Therapeutics

You are here: Home >> SPi Company Listings >> Mateon Therapeutics

 

Mateon Therapeutics

Website:
http://

Search for other references to "mateon" on SPi News

Latest Mateon Therapeutics News

Mateon Reports First Quarter 2019 Financial Results SOUTH SAN FRANCISCO, Calif., May 15, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatme...... 14:39 GMT Wednesday 15th May 2019

Mateon and Oncotelic Complete Their Merger and Create a New Immuno-Oncology Company with a Late-Stage Clinical Asset Against Cancer and a Promising Product Pipeline SOUTH SAN FRANCISCO, Calif. and AGOURA HILLS, Calif., April 25, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) and Oncotelic Inc. announced today that they have...... 11:35 GMT Thursday 25th April 2019

Mateon Enters into Merger Agreement with Oncotelic SOUTH SAN FRANCISCO, Calif. and AGOURA HILLS, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN) and Oncotelic Inc., a privately-held, late clinica...... 11:01 GMT Thursday 18th April 2019

Mateon Therapeutics Reports Third Quarter 2018 Financial Results SOUTH SAN FRANCISCO, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology in...... 13:45 GMT Wednesday 14th November 2018

Mateon Therapeutics to Present at the Rodman & Renshaw Investor Conference on September 6, 2018 SOUTH SAN FRANCISCO, Calif., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (OTCQB:MATN), a biopharmaceutical company developing drugs for the treatment of orphan on...... 14:00 GMT Thursday 30th August 2018

Mateon Therapeutics Receives Notice of Partial Clinical Hold for OX1222 Study SOUTH SAN FRANCISCO, Calif., Aug. 17, 2018 (GLOBE NEWSWIRE) -- (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology in...... 13:50 GMT Friday 17th August 2018

Mateon Therapeutics Reports Second Quarter 2018 Financial Results SOUTH SAN FRANCISCO, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- (OTCQB:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology in...... 21:25 GMT Tuesday 14th August 2018

Mateon Therapeutics Reports First Quarter 2018 Financial Results SOUTH SAN FRANCISCO, Calif., May 14, 2018 (GLOBE NEWSWIRE) -- (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology ind...... 12:45 GMT Monday 14th May 2018

Mateon Therapeutics Provides Business Update and Reports 2017 Financial Results SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology i...... 21:35 GMT Monday 16th April 2018

Mateon Therapeutics Raises Net Proceeds of Approximately $2.4 Million in Financing Transaction SOUTH SAN FRANCISCO, Calif., April 16, 2018 (GLOBE NEWSWIRE) -- . (OTCQX:MATN), a biopharmaceutical company developing investigational drugs for the treatment of orphan oncology...... 21:10 GMT Monday 16th April 2018

Buy Mateon Therapeutics
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us